Search

everythinglearnresearchcommunity

for

Search:↓

AR gene not major factor in female hair loss; different from male hair loss.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.